PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung

BACKGROUND: With introduction of immunotherapy (IT) into the treatment of advanced non-small-cell lung cancer (NSCLC), a need for predictive biomarker became apparent. Programmed death ligand 1 (PD-L1) protein expression is most widely explored predictive marker for response to IT. We assessed PD-L1...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiol Oncol
Autori principali: Janzic, Urska, Kern, Izidor, Janzic, Andrej, Cavka, Luka, Cufer, Tanja
Natura: Artigo
Lingua:Inglês
Pubblicazione: De Gruyter Open 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612001/
https://ncbi.nlm.nih.gov/pubmed/28959173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/raon-2017-0037
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi